About Juan M Hincapie-Castillo
Juan M. Hincapie-Castillo, Pharm.D, M.S., Ph.D., joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2019. He is a graduate from the University of Florida College of Pharmacy where he received the degrees of Doctor of Pharmacy (2013), Master of Science in Pharmaceutical Sciences (2017), and Ph.D. with a concentration in pharmacoepidemiology (2019). He is the recipient of the 2020 New Investigator Award from the American Association of Colleges of Pharmacy and the 2020 Emerging Leader Award from the International Society for Pharmacoepidemiology (ISPE). His research interests include the study of drug utilization and safety in the area of pain management, the evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and the assessment of patient safety and quality for inpatient pain management. He is the current chair of the Latin American Regional Interest Group for ISPE, and he is a consultant for the FDA’s Drug Safety and Risk Management Advisory Committee.
Drug utilization and safety in pain management, evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and assessment of patient safety and quality for inpatient pain management.
- Legal Epidemiology
- Pain Management
- health services research
Dr. Hincapie-Castillo has been appointed as a consultant to the FDA’s Drug Safety and Risk Management Advisory Committee.
The Emerging Leader Award recognizes ISPE members that have shown early in their careers the potential for leadership and have already made significant contributions to the society.
Juan Hincapie-Castillo, Pharm.D., Ph.D., an assistant professor in the UF College of Pharmacy’s department of pharmaceutical outcomes and policy, has received a $10,000 grant from the American Association of Colleges…
UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.